SGLT2i: Overview of recent trials and guideline recommendations
Lecture 2 out of 3
This lecture by Nicolaus Marx was part of an accredited symposium " Teaming up to tackle cardiorenal risk in diabetes - Role of SGLT2i: How to overcome clinical inertia" held during the virtual EASD 2021.
Prof. Nikolaus Marx, Professor of Medicine / Cardiology, Head of Department of Internal Medicine I, Cardiology, Angiology, and Intensive Care Medicine, University Hospital Aachen, Germany.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
Funding for this educational program was provided by an unrestricted educational grant received from Boehringer Ingelheim / Lilly.